VAN EĞİTİM VE ARAŞTIRMA HASTANESİNDEKİ HEMODİYALİZ HASTALARINDA HBV, HCV VE HİV SEROLOJİK İNDİKATÖRLERİ

SEROLOGIC INDICATORS OF HBV, HCV AND HIV IN HEMODIALYSIS PATIENTS IN VAN TRAINING AND RESEARCH HOSPITAL

Özet

AMAÇ: Bu çalışmada, kronik böbrek yetmezliği tanısıyla hemodiyalizuygulanan hastalarda; kan yoluyla bulaşan enfeksiyonlar incelenerekenfeksiyon kontrol programlarının etkinliğinin değerlendirilmesiamaçlanmıştır.GEREÇ VE YÖNTEM: Çalışmada 1 Ocak- 1 Ağustos 2018 tarihleriarasında rutin hemodiyaliz uygulanan hastaların dosyaları restrospektifolarak incelendi. Hastaların demografik özellikleri ve hastanemizmikrobiyoloji laboratuvarında macro ELİSA yöntemi ile çalışılanHBsAg, Anti-HBs, Anti-HCV ve Anti-HİV serolojileri kaydedildi.BULGULAR: Hemodiyaliz sonrası HBsAg ve Anti-HİV reaktifliğigelişen hasta bulunmamakta olup; Anti-HCV reaktifliği olan yedihasta saptandı. Anti-HCV reaktif hastaların beş yıldan daha uzundiyalize girdiği ve yaş ortalamalarının daha düşük olduğu saptandı(p

Abstract

INTRODUCTION: It was aimed to examine the blood-borne infections in patients to whom hemodialysis is applied due to chronic renal failure and evaluating the effectiveness of infection control programs in this study. MATERIALS AND METHODS: Patients who underwent routine hemodialysis between January and August 2018 were included into the study. The study was designed as a retrospective. The blood samples taken from patients during their health screenings were tested with the macro ELISA method for HBsAg, Anti-HBs, AntiHCV and Anti-HIV observations at the microbiology laboratory and the clinical information was acquired from patient files. RESULTS: There were no patients who developed reactivity of chronic HBsAg and anti-HIV based on dialysis. One of eight AntiHCV reactive patients was not included in the analyses since the patient had the disease before undergoing dialysis. It was detected that Anti-HCV reactive patients underwent dialysis for more than five years and they had a lower mean age (p